Positive Data on ABT's Kidney Drug - Zacks.com PDF Print
Zacks.com... Pharmaceuticals recently announced positive data on their chronic kidney disease candidate, bardoxolone methyl, at the American Society of Nephrology. ...Reata Pharmaceuticals and Abbott present encouraging clinical data at American ... Trading Markets (press release)Abbott Announces Positive Results from Phase 2 Study of Low Dose Atrasentan

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.